The role of microglial activation on ischemic stroke: modulation by fibroblast growth factors
Confidence Dordoe,Wenting Huang,Canol Bwalya,Xue Wang,Bixin Shen,Hao Wang,Jing Wang,Shasha Ye,Peng Wang,Bao Xiaoyan,Xiaokun Li,Li Lin
DOI: https://doi.org/10.1016/j.cytogfr.2023.07.005
2023-08-02
Abstract:Stroke is one of the devastating clinical conditions that causes death and permanent disability. Its occurrence causes the reduction of oxygen and glucose supply, resulting in events such as inflammatory response, oxidative stress, and apoptosis in the brain. Microglia are brain-resident immune cells in the central nervous system (CNS) that exert diverse roles and respond to pathological process after an ischemic insult. The discovery of fibroblast growth factors (FGFs) in mammals, resulted to the findings that they can treat experimental models of stroke in animals effectively. FGFs function as homeostatic factors that control cells and hormones involved in metabolism, and they also regulate the secretion of proinflammatory (M1) and anti-inflammatory (M2) cytokines after stroke. In this review, we outline current evidence of microglia activation in experimental models of stroke focusing on its ability to exacerbate damage or repair tissue. Also, our review sheds light on the pharmacological actions of FGFs on multiple targets to regulate microglial modulation and highlighted their theoretical molecular mechanisms to provide possible therapeutic targets, as well as their limitations for the treatment of stroke. Data Availability Not applicable
biochemistry & molecular biology,cell biology